Search results (573)
« Back to PublicationsRisk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B
Journal article
Kalafateli M. et al, (2026), Clinical Gastroenterology and Hepatology, 24, 701 - 712.e8
Response to Comments on ‘Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines’
Journal article
Campbell C. et al, (2026), Journal of Viral Hepatitis, 33
CE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation
Journal article
Tipton T. et al, (2026), Vaccine, 72, 128123 - 128123
ssociation between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies
Journal article
Danysz M. et al, (2026), Clinical Microbiology and Infection, 32, 41 - 55
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross‐Sectional Study
Journal article
Drysdale M. et al, (2025), Journal of Viral Hepatitis, 32
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity
Journal article
Kronsteiner B. et al, (2025), Scientific Reports, 15
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies
Journal article
Strain R. et al, (2025), Hepatology
Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines
Journal article
Campbell C. et al, (2025), Journal of Viral Hepatitis, 32
HCV response-guided therapy: is shorter always better? – Authors' reply
Journal article
Cooke GS. et al, (2025), The Lancet, 406, 2540 - 2540
Genome-wide association and gene-virus interaction study of liver disease in hepatitis C virus-infected patients
Preprint
Quistrebert J. et al, (2025)
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design
Journal article
Wang Z. et al, (2025), Cell Reports, 44, 116418 - 116418
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa
Journal article
Downs LO. et al, (2025), Journal of Infection, 91, 106601 - 106601
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines
Journal article
Amini A. et al, (2025), Science Immunology, 10
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines
Journal article
Murray SM. et al, (2025), Science Immunology, 10
Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1
Journal article
Pudjohartono MF. et al, (2025), PLOS Pathogens, 21, e1013432 - e1013432